Markets › United States › NYSE › CRL

Charles River Laboratories International Inc

NYSE:CRLHealthcareCBOE:SPESGNASDAQ:NQUSMG

$300.02−0.04%At closeAt close · Tue 20 Oct · ≈ AED 1,101.82 · Market cap $14.32B · Next earnings Wed 4 Nov

Report	EPS est.	Actual	Surprise	Revenue est.	Revenue
Wed, 5 Aug 2026	$2.74	−$0.0309	−101.1%	$977.2M	$1B
Thu, 7 May 2026	$1.96	$2.06	+5.1%	$977.46M	$995.83M
Wed, 18 Feb 2026	$2.33	$2.39	+2.6%	$987.02M	$994.23M
Wed, 5 Nov 2025	$2.32	$2.43	+4.7%	$987.2M	$1B
Wed, 6 Aug 2025	$2.50	$3.12	+24.8%	$968.92M	$1.03B
Wed, 7 May 2025	$2.06	$2.34	+13.6%	$958.79M	$984.17M
Wed, 19 Feb 2025	$2.50	$2.66	+6.4%	$948.22M	$1B
Wed, 6 Nov 2024	$2.42	$2.59	+7.0%	$975.99M	$1.01B